Moderna downsizes shipments in the UK and Canada for supply chain issues

Photographer: David Paul Morris / Bloomberg

Moderna Inc. said it will deliver less Covid-19 vaccine than planned to the UK, Canada and other countries this quarter due to a shortage of doses in its European supply chain.

Moderna, which works with a Swiss partner Lonza Group AG to shoot in Europe attributed the reduction in deliveries to a slower than expected increase in production capacity. Moderna has its own factory in Massachusetts that serves the US

The reduced deliveries to other countries will further limit the global supply of vaccines, with injections from Johnson & Johnson on hold in much of the world due to concerns about a link with rare but dangerous blood clots, a problem that has also led to restrictions on the use of AstraZeneca Plc’s vaccine in Europe.

“The trajectory of the increase in vaccine production is not linear, and despite best efforts, there is a shortage of previously estimated doses,” Moderna said in a statement Friday. “Vaccine production is a very complex process and a number of elements, including human and material resources, have taken this volatility into account.”

Shipments to the UK will be reduced from this month, just days after the Moderna vaccine was rolled out in Britain, which will affect the total number of doses expected to be delivered by the end of June.

UK program

Source